Viewing Study NCT00520806


Ignite Creation Date: 2025-12-26 @ 4:03 PM
Ignite Modification Date: 2026-02-24 @ 8:27 AM
Study NCT ID: NCT00520806
Status: COMPLETED
Last Update Posted: 2012-10-30
First Post: 2007-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Relaxin for the Treatment of Acute Heart Failure
Sponsor: Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure, Congestive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Heart failure View
None Renal dysfunction View
None Relaxin View
None Vasodilator View